FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.92, $0.20 better than the analyst estimate of $0.72. Revenue for the quarter came in at $206.4 million versus the consensus estimate of $185.48 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.07-$3.15, versus the consensus of $3.25. Repligen sees... More

